Observational studyDigestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society2026
EUS-Guided Gastroenterostomy for Malignant Gastric Outlet Obstruction: Morphological Classification to Prevent Stent Misdeployment.
Observational study in Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07230665 (Outcome of Patients With Malignant Gastric Outlet Obstruction Undergoing Endoscopic Ultrasound-guided Gastroenterostomy or Enteral Metal Stenting), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Outcome of Patients With Malignant Gastric Outlet Obstruction Undergoing Endoscopic Ultrasound-guided Gastroenterostomy or Enteral Metal Stenting: a Prospective Cohort Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveStent misdeployment is the most critical adverse event (AE) during endoscopic ultrasound-guided gastroenterostomy (EUS-GE). This study aimed to identify predictors of misdeployment in EUS-GE for malignant gastric outlet obstruction (mGOO).
methodsThis multicenter observational study utilized a prospectively maintained registry of consecutive patients undergoing EUS-GE for mGOO at 13 tertiary centers in Taiwan, with mixed retrospective-prospective assessment of fluoroscopic morphology (FM) of the gastrointestinal tract near the ligament of Treitz (four types) and EUS morphology (EM) of the target bowel (three types). The primary outcome was the misdeployment. Multivariable analysis identified predictors of misdeployment and survival.
resultsBetween July 2020 and June 2025, 165 patients were enrolled. Technical and clinical success rates were 98.2% and 95.2%, respectively. Overall AE rate and misdeployment rates were 7.3% and 4.8%, respectively. Same-session endoscopic salvage succeeded in 87.5% of misdeployment cases. EM type C (cross-sectional bowel view) carried the highest misdeployment risk (33%) and was the sole independent predictor (adjusted odds ratio 16.9; p = 0.001). FM provided essential complementary risk stratification; FM type II was more common among misdeployment cases (25.0% vs. 3.8%; p = 0.030). Implementation of a stepwise strategy in 2023-prioritizing EM type A/B, avoiding type C, and minimizing stomach-bowel distance-resulted in zero misdeployment. Independent predictors of poor survival included pancreatic cancer, malnutrition, poor performance status, ascites, metastasis, and misdeployment.
conclusionStent misdeployment is a significant complication adversely impacting survival. Utilizing integrated EM and FM risk stratification within a stepwise strategy can minimize misdeployment and optimize clinical outcomes.
trial registrationClinicalTrials.gov: NCT07230665.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.